DT
BSX icon

DV Trading’s Boston Scientific BSX Stock Holding History

DV Trading’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,483
Closed -$219K – 545
2026
Q1 		$219K Buy
3,483
+3,482
+348,200% +$279K 0.01% 432
2025
Q4 		$95 Buy
+1
New +$98 ﹤0.01% 1063

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

DV Trading's BSX Position: Q2 2026 in Review

DV Trading sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 3,483 shares — an estimated $219K sold.

DV Trading first reported a position in BSX in Q4 2025 and held it in 2 quarters. The position peaked at $219K in Q1 2026. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • DV Trading reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • DV Trading sold 3,483 Boston Scientific shares in Q2 2026, an estimated $219K.
  • DV Trading first reported a position in Boston Scientific in Q4 2025 and held it in 2 quarters.
  • DV Trading's Boston Scientific position peaked at $219K in Q1 2026.
  • 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on DV Trading's 13F filing for Q2 2026, filed 14 Aug 2026.